Reviva Pharmaceuticals Holdings, Inc. Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Dividend Rate
Reviva Pharmaceuticals Holdings, Inc. (RVPH) reported Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Dividend Rate of 0.00% for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-15.
Discontinued › Notes › Compensation Related Costs
us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate · last filed 2022-03-15
- Reviva Pharmaceuticals Holdings, Inc. share-based goods and nonemployee services transaction, valuation method, expected dividend rate for fiscal 2021 was 0.00%.
| Period end | Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Dividend Rate 6 month | Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Dividend Rate 9 month | Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Dividend Rate 12 month |
|---|---|---|---|
| 2021-12-31 | 0.00% 10-K · filed 2022-03-15 | ||
| 2021-09-30 | 0.00% 10-Q · filed 2021-11-15 | ||
| 2021-06-30 | 0.00% 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |